retatrutide approval 2025 FDA Status 2026: Everything We Know So Far Retatrutide—A Game Changer in Obesity

One MOAA member made his case in a commentary at Military Times, where he shared his personal story while detailing the questionable path DHA officials took to reach their decision

Every piece of clinical evidence supports it

Who Gets Access and Who Doesnt Eligibility depends on both plan and clinical criteria

Official documentation predominantly features gastrointestinal symptoms like nausea, diarrhoea, and vomiting rather than temperature regulation issues

Seek urgent medical attention if you experience: Severe, persistent abdominal pain (especially if radiating to the back) with or without vomiting, which could indicate pancreatitis Right upper quadrant pain, fever, or yellowing of the skin/eyes, which might suggest gallbladder disease Severe chest pain, difficulty breathing, facial swelling, or signs of an allergic reaction For urgent advice, call NHS 111

Pros and Cons of Switching Medications Switching to a different GLP-1 receptor agonist or another type of diabetes medication has its benefits and challenges